Home › Funds › Broadhurst Jeffrey B › GMED
Broadhurst Jeffrey B position in GMED
GLOBUS MED INC · Health Care
Broadhurst Jeffrey B reported holding 19,899 shares of GMED (GLOBUS MED INC) in its Q3 2026 13F filing — a position valued at US$1.5M, representing 1.40% of its reported portfolio and ranking #21 among its reported holdings. Broadhurst Jeffrey B has disclosed GMED holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Broadhurst Jeffrey B's GMED position evolved
Broadhurst Jeffrey B first disclosed a stake in GMED in Q4 2025 at 23,058 shares (US$2.0M). Across 4 filings, Broadhurst Jeffrey B increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 19,899 shares valued at US$1.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 23.06K | $2.01M | New |
| Q1 2026 | 23.05K | $1.99M | Hold |
| Q2 2026 | 19.84K | $1.57M | Reduce |
| Q3 2026 | 19.90K | $1.49M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GMED and 13F data
GMED (GLOBUS MED INC) is a Health Care company. 39 other funds we track also report a position in GMED — the largest reported positions include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$338.1M), Sculptor Capital LP (US$237.0M), Boston Trust Walden Corp (US$124.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMED
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 4.28M sh · $338.14M · Q2 2026
- Sculptor Capital LP 3.00M sh · $237.03M · Q2 2026
- Boston Trust Walden Corp 1.57M sh · $124.31M · Q2 2026
- GW&K Investment Management, LLC 1.45M sh · $114.82M · Q2 2026
- GENEVA CAPITAL MANAGEMENT LLC 1.42M sh · $111.96M · Q2 2026
- Madison Avenue Partners, LP 935.22K sh · $73.89M · Q2 2026
- ANTIPODES PARTNERS Ltd 905.98K sh · $71.58M · Q2 2026
- PARADIGM CAPITAL MANAGEMENT INC/NY 886.50K sh · $70.04M · Q2 2026
More on Broadhurst Jeffrey B
FAQ
How long has Broadhurst Jeffrey B held GMED?
Broadhurst Jeffrey B has disclosed GMED holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Broadhurst Jeffrey B's current position in GMED?
As of Q3 2026, Broadhurst Jeffrey B holds 19.90K shares of GMED (GLOBUS MED INC), valued at $1.49M, representing 1.40% of its reported portfolio and ranking #21.
Has Broadhurst Jeffrey B been buying or selling GMED?
In the latest 13F filing (Q3 2026), Broadhurst Jeffrey B held unchanged its position in GMED.
Which other funds hold GMED?
Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Sculptor Capital LP, Boston Trust Walden Corp, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.